Companion Animal Health Market

Companion Animal Health Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Animal (Dogs, Cats, Avian, Equine and Other Animals), Type of Product (Pharmaceuticals, Vaccines, Medicated Feed Additives, Medical Devices, Diagnostics and Veterinary Services), Type of Health Concern (Infectious Diseases, Chronic Diseases, Nutritional Disorders and Preventive Care), Distribution Channel (Hospital Pharmacies, e-Commerce and Retailers), End User (Veterinary Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings, and Other End Users), Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and Leading Players

  • Lowest Price Guaranteed

  • Slides
    237

  • Last Updated
    September 2025

  • View Count
    14646

Table of Content

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Hospitals

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Companion Animal Health
6.2.1. Market Drivers
6.2.2. Market Restraints
6.2.3. Market Opportunities

6.3. Future Perspective

7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Companion Animal Health Companies: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters

7.2.4. Companion Animal Health Products and Services: Overall Market Landscape
7.2.4.1. Analysis by Imaging Animal Type
7.2.4.2. Analysis by Product Type
7.2.4.3. Analysis by Health Concern Type
7.2.4.4. Analysis by Distribution Channel Type
7.2.4.5. Analysis by End Users

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies

8.4. Company Competitiveness Analysis: Companion Animal Health Companies
8.4.1. Companion Animal Health Companies Based in North America (Peer Group 1)
8.4.2. Companion Animal Health Companies Based in Europe (Peer Group 2)
8.4.3. Companion Animal Health Companies Based in Asia-Pacific (Peer Group 3)
8.4.4. Companion Animal Health Companies Based in Middle East and North Africa, and Latin America (Peer Group 4)

8.5. Key Findings

9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Agrolabo
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook

* Similar detail is presented for other below mentioned companies based on information in the public domain

9.3. Boehringer Ingelheim International
9.4. Bayer
9.5. Ceva Animal Health
9.6. Dechra Pharmaceuticals
9.7. Elanco Animal Health
9.8. Heska
9.9. IDEXX Laboratories
9.10. Merck
9.11. Neogen
9.12. Norbrook
9.13. Ourofino Saúde Animal
9.14. Phibro Animal Health
9.15. Virbac
9.16. Vetoquinol
9.17. Zoetis

10. SWOT ANALYSIS

11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL COMPANION ANIMAL HEALTH MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global Companion Animal Health Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario

12.6. Key Market Segmentations

13. MARKET OPPORTUNITIES BASED ON TYPE OF ANIMAL
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix
13.6. Companion Animal Health Market for Dogs: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7. Companion Animal Health Market for Cats: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8. Companion Animal Health Market for Avian: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.9. Companion Animal Health Market for Equine: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.10. Companion Animal Health Market for Other Animals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.11. Data Triangulation and Validation

14. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix

14.6. Companion Animal Health Market for Pharmaceuticals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.1. Companion Animal Health Market for Drugs: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.1.1. Companion Animal Health Market for Anti-Parasitic: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.1.2. Companion Animal Health Market for Anti-Infectives: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.1.3. Companion Animal Health Market for Anti-Inflammatory: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.1.4. Companion Animal Health Market for Other Drugs: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

14.6.2. Companion Animal Health Market for Vaccines: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.2.1. Companion Animal Health Market for Modified Live Vaccines: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.2.2. Companion Animal Health Market for Killed Inactivated Vaccines: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.2.3. Companion Animal Health Market for Other Vaccines: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

14.6.3. Companion Animal Health Market for Medicated Feed Additives: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.1. Companion Animal Health Market for Antibiotics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.2. Companion Animal Health Market for Vitamins: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.3. Companion Animal Health Market for Enzymes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.4. Companion Animal Health Market for Amino Acids: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.5. Companion Animal Health Market for Antibiotics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.6. Companion Animal Health Market for Prebiotics and Probiotics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.7. Companion Animal Health Market for Minerals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.6.3.8. Companion Animal Health Market for Other Medicated Feed Additives: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

14.7. Companion Animal Health Market for Medical Devices: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7.1. Companion Animal Health Market for Veterinary Diagnostic Equipment: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7.2. Companion Animal Health Market for Veterinary Anesthesia Equipment: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7.3. Companion Animal Health Market for Veterinary Patient Monitoring Equipment: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7.4. Companion Animal Health Market for Veterinary Surgical Equipment: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7.5. Companion Animal Health Market for Veterinary Consumables: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7.6. Companion Animal Health Market for Other Medical Devices: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

14.8. Companion Animal Health Market for Diagnostics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8.1. Companion Animal Health Market for Immunodiagnostic Tests: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8.2. Companion Animal Health Market for Molecular Diagnostics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8.3. Companion Animal Health Market for Diagnostic Imaging: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8.4. Companion Animal Health Market for Other Diagnostics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

14.9. Companion Animal Health Market for Veterinary Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.10. Data Triangulation and Validation

15. MARKET OPPORTUNITIES BASED ON TYPE OF HEALTH CONCERN
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. Companion Animal Health Market for Infectious Diseases: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.7. Companion Animal Health Market for Chronic Diseases: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.8. Companion Animal Health Market for Nutritional Disorders: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.9. Companion Animal Health Market for Preventive Care: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.10. Data Triangulation and Validation

16. MARKET OPPORTUNITIES BASED ON TYPE OF DISTRIBUTION CHANNEL
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Companion Animal Health Market for Hospital Pharmacies: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7. Companion Animal Health Market for e-Commerce: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8. Companion Animal Health Market for Retailers: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9. Data Triangulation and Validation

17. MARKET OPPORTUNITIES BASED ON TYPE OF END USER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Companion Animal Health Market for Veterinary Hospitals & Clinics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.7. Companion Animal Health Market for Diagnostic Laboratories: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.8. Companion Animal Health Market for Research Institutes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.9. Companion Animal Health Market for Home Care Settings: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.10. Companion Animal Health Market for Other End Users: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.11. Data Triangulation and Validation

18. MARKET OPPORTUNITIES FOR COMPANION ANIMAL HEALTH IN NORTH AMERICA
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix

18.6. Companion Animal Health Market in North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.1. Companion Animal Health Market in the US: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.2. Companion Animal Health Market in Canada: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.3. Companion Animal Health Market in Mexico: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

18.7. Data Triangulation and Validation

19. MARKET OPPORTUNITIES FOR COMPANION ANIMAL HEALTH IN EUROPE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix

19.6. Companion Animal Health Market in Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.1. Companion Animal Health Market in Germany: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.2. Companion Animal Health Market in France: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.3. Companion Animal Health Market in Italy: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.4. Companion Animal Health Market in Spain: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.5. Companion Animal Health Market in the UK: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.6. Companion Animal Health Market in Rest of Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

19.7. Data Triangulation and Validation

20. MARKET OPPORTUNITIES FOR COMPANION ANIMAL HEALTH IN ASIA-PACIFIC
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix

20.6. Companion Animal Health Market in Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.1. Companion Animal Health Market in China: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.2. Companion Animal Health Market in India: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.3. Companion Animal Health Market in Japan: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.4. Companion Animal Health Market in South Korea: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.5. Companion Animal Health Market in Australia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.6. Companion Animal Health Market in Russia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.7. Companion Animal Health Market in Thailand: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.8. Companion Animal Health Market in Malaysia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.9. Companion Animal Health Market in Indonesia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.10. Companion Animal Health Market in Rest of the Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

20.7. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR COMPANION ANIMAL HEALTH IN MIDDLE EAST AND NORTH AFRICA (MENA)
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. Companion Animal Health Market in Middle East and North Africa (MENA): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.1. Companion Animal Health Market in Egypt: Historical Trends (Since 2019) and Forecasted Estimates (Till 205)
21.6.2. Companion Animal Health Market in Saudi Arabia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.3. Companion Animal Health Market in United Arab Emirates (UAE): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR COMPANION ANIMAL HEALTH IN LATIN AMERICA
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. Companion Animal Health Market in Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.1. Companion Animal Health Market in Argentina: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.2. Companion Animal Health Market in Brazil: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. APPENDIX 1: TABULATED DATA

24. APPENXID 2: LIST OF COMPANIES AND ORGANIZATIONS

25. CUSTOMIZATION OPPORTUNITIES

26. ROOTS SUBSCRIPTION SERVICES

27. AUTHOR DETAIL